BioChem, Vertex deal

BCHXF's BioChem Therapeutic Inc. subsidiary signed an exclusive license and supply agreement to develop and market VTRX's VX-710 in Canada. VX-710, VTRX's lead multidrug resistance reversal agent, is ...